Rights accessRestricted access - publisher's policy
Evidence-based medicine has grown in stature over three decades and is now regarded a key development of modern medicine. The evidence base can be heterogeneous, involving both qualitative knowledge and measured quantitative data. Data analysis in the area of cancer research has for long been the playing field of statisticians but, over the last decade, Machine Learning (ML) methods have also begun to establish themselves an an alternative and promising approach to computer-based data analysis in oncology. In this chapter, we provide a state-of-the-art in the main areas of cancer research in which ML methods are currently being applied, and discuss some of the advantages and disadvantages of their application. We also comment on and illustrate the integration of ML methods in clinical oncology decision support systems.
CitationVellido, A.; Lisboa, P. Machine learning in human cancer research. A: "Neurocomputing research developments". Nova Science Publishers, 2007, p. 163-180.
All rights reserved. This work is protected by the corresponding intellectual and industrial property rights. Without prejudice to any existing legal exemptions, reproduction, distribution, public communication or transformation of this work are prohibited without permission of the copyright holder. If you wish to make any use of the work not provided for in the law, please contact: firstname.lastname@example.org